The global chronic idiopathic constipation (CIC) drugs market is moderately competitive and is characterized by a large demand for over the counter medications. Considering CIC as a symptom and not a disorder, there is a greater tendency of patients towards opting for self-medication through OTC drugs. This report on CIC drugs market studies, estimates and forecasts the market for various drugs indicated for the treatment of chronic idiopathic constipation. The global CIC drugs market report studies this market for drug types, prescription type and geographical distribution.
In terms of drug type, the global CIC market is studied for Lubiprostone, Linaclotide and other drugs. The market size and forecast for these segments is provided for the period 2020-2030, with respective CAGRs for the period 2022-2030, while considering 2021 as the base year. In addition, this report also studies the market prospects for Plecanatide and Elobixibat, the phase 3 CIC drugs.
The prescription-based market for CIC drugs is classified as prescribed CIC drugs market and OTC CIC drugs markets. The prescribed drugs market is further categorized into branded prescribed and generic prescribed CIC drugs segments.
In terms of geographic distribution, North America, Europe, Asia Pacific and rest of the world regions cumulatively make the global CIC drugs market. These regional markets are further studied for key countries that determine the overall market trends in the regions.
This report includes qualitative market analysis tools such as attractive investment proposition, market dynamics, competition mapping and others. The report concludes with mapping of the key CIC drugs manufacturers operating in the global CIC drugs market.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
In terms of drug type, the global CIC market is studied for Lubiprostone, Linaclotide and other drugs. The market size and forecast for these segments is provided for the period 2020-2030, with respective CAGRs for the period 2022-2030, while considering 2021 as the base year. In addition, this report also studies the market prospects for Plecanatide and Elobixibat, the phase 3 CIC drugs.
The prescription-based market for CIC drugs is classified as prescribed CIC drugs market and OTC CIC drugs markets. The prescribed drugs market is further categorized into branded prescribed and generic prescribed CIC drugs segments.
In terms of geographic distribution, North America, Europe, Asia Pacific and rest of the world regions cumulatively make the global CIC drugs market. These regional markets are further studied for key countries that determine the overall market trends in the regions.
This report includes qualitative market analysis tools such as attractive investment proposition, market dynamics, competition mapping and others. The report concludes with mapping of the key CIC drugs manufacturers operating in the global CIC drugs market.
Historical - Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Global Chronic Idiopathic Constipation (CIC) Drugs market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Global Chronic Idiopathic Constipation (CIC) Drugs market and their expected impact during the forecast period.
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Global Chronic Idiopathic Constipation (CIC) Drugs market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Global Chronic Idiopathic Constipation (CIC) Drugs market?
- Which is the largest regional market for Global Chronic Idiopathic Constipation (CIC) Drugs market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East - Africa?
- Which are the key trends driving Global Chronic Idiopathic Constipation (CIC) Drugs market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Global Chronic Idiopathic Constipation (CIC) Drugs market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Global Chronic Idiopathic Constipation (CIC) Drugs Market
2.2. Global Global Chronic Idiopathic Constipation (CIC) Drugs Market, By Drug Type, 2021 (US$ Million)
2.3. Global Global Chronic Idiopathic Constipation (CIC) Drugs Market, By Prescription Type, 2021 (US$ Million)
2.4. Global Global Chronic Idiopathic Constipation (CIC) Drugs Market, By Geography, 2021 (US$ Million)
2.5. Impact of Covid 19
2.6. Attractive Investment Proposition by Geography, 2021
2.7. Competitive Analysis
2.7.1. Market Positioning of Key Global Chronic Idiopathic Constipation (CIC) Drugs Market Vendors
2.7.2. Strategies Adopted by Global Chronic Idiopathic Constipation (CIC) Drugs Market Vendors
2.7.3. Key Industry Strategies
2.7.4. Tier Analysis 2021 Versus 2030
2.8. Key Buying Criteria
2.9. Key Case Reports
2.10. Scenario Analysis
2.10.1. Optimistic estimates and analysis
2.10.2. Realistic estimates and analysis
2.10.3. Pessimistic estimates and analysis
2.11. Market Profiling
2.12. Sales and Marketing Plan
2.13. Top Market Conclusions
2.14. Strategic Recommendations
3. Global Chronic Idiopathic Constipation (CIC) Drugs Market: Business Outlook & Market Dynamics
3.1. Introduction
3.2. Global Global Chronic Idiopathic Constipation (CIC) Drugs Market Value, 2020 - 2030, (US$ Million)
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.2. Market Restraints
3.3.3. Key Challenges
3.3.4. Key Opportunities
3.4. Impact Analysis of Drivers and Restraints
3.5. See-Saw Analysis
3.6. Porter’s Five Force Model
3.6.1. Supplier Power
3.6.2. Buyer Power
3.6.3. Threat Of Substitutes
3.6.4. Threat Of New Entrants
3.6.5. Competitive Rivalry
3.7. PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Economic Landscape
3.7.3. Technology Landscape
3.7.4. Legal Landscape
3.7.5. Social Landscape
3.8. Heptalysis Analysis
3.9. Critical Investigation of Business Problems Through Five Whys Root Cause Analysis & Relevant Solutions
4. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth & Revenue Analysis: 2021 Versus 2030
4.3. Market Segmentation
4.3.1. Lubiprostone
4.3.2. Linaclotide5. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Prescribed Drugs
5.3.2. Over the Counter Drugs
6. North America Global Chronic Idiopathic Constipation (CIC) Drugs Market, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
6.3. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
6.4. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Region, 2020-2030, USD (Million)
6.4.1. North America
6.4.1.1. U.S.
6.4.1.1.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
6.4.1.1.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
6.4.1.2. Canada
6.4.1.2.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
6.4.1.2.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
6.4.1.3. Rest of North America
6.4.1.3.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
6.4.1.3.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
7. UK and European Union Global Chronic Idiopathic Constipation (CIC) Drugs Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.3. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
7.4. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Region, 2020-2030, USD (Million)
7.4.1. UK and European Union
7.4.1.1. UK
7.4.1.1.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.1.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
7.4.1.2. Germany
7.4.1.2.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.2.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
7.4.1.3. Spain
7.4.1.3.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.3.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
7.4.1.4. Italy
7.4.1.4.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.4.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
7.4.1.5. France
7.4.1.5.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.5.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
7.4.1.6. Rest of Europe
7.4.1.6.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.6.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
8. Asia Pacific Global Chronic Idiopathic Constipation (CIC) Drugs Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.3. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
8.4. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Region, 2020-2030, USD (Million)
8.4.1. Asia Pacific
8.4.1.1. China
8.4.1.1.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.1.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
8.4.1.2. Japan
8.4.1.2.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.2.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
8.4.1.3. India
8.4.1.3.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.3.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
8.4.1.4. Australia
8.4.1.4.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.4.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
8.4.1.5. South Korea
8.4.1.5.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.5.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
8.4.1.6. Rest of Asia Pacific
8.4.1.6.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.6.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
9. Latin America Global Chronic Idiopathic Constipation (CIC) Drugs Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
9.3. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
9.4. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Region, 2020-2030, USD (Million)
9.4.1. Latin America
9.4.1.1. Brazil
9.4.1.1.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
9.4.1.1.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
9.4.1.2. Mexico
9.4.1.2.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
9.4.1.2.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
9.4.1.3. Rest of Latin America
9.4.1.3.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
9.4.1.3.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
10. Middle East and Africa Global Chronic Idiopathic Constipation (CIC) Drugs Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
10.3. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
10.4. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Region, 2020-2030, USD (Million)
10.4.1. Middle East and Africa
10.4.1.1. GCC
10.4.1.1.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
10.4.1.1.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
10.4.1.2. Africa
10.4.1.2.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
10.4.1.2.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
10.4.1.3. Rest of Middle East and Africa
10.4.1.3.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2020-2030, USD (Million)
10.4.1.3.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2020-2030, USD (Million)
11. Company Profile
11.1. Actavis
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Chugai Pharmaceutical
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Ferring International Center S.A.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Synergy Pharmaceuticals
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Pfizer
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. GlaxoSmithKline
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Roche Holding AG
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Sanofi
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Bayer AG
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Salix Pharmaceuticals Ltd
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
11.11. Sucampo Pharmaceuticals Inc
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Portfolio
11.11.4. Strategic Initiatives
11.12. Ironwood Pharmaceuticals inc
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Portfolio
11.12.4. Strategic Initiatives
11.13. Progenics pharmaceuticals inc
11.13.1. Company Overview
11.13.2. Financial Performance
11.13.3. Product Portfolio
11.13.4. Strategic Initiatives
List of Figures
Figure 1 Global Global Chronic Idiopathic Constipation (CIC) Drugs Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Global Chronic Idiopathic Constipation (CIC) Drugs Market: Quality Assurance
Figure 5 Global Global Chronic Idiopathic Constipation (CIC) Drugs Market, By Drug Type, 2021
Figure 6 Global Global Chronic Idiopathic Constipation (CIC) Drugs Market, By Prescription Type, 2021
Figure 7 Global Global Chronic Idiopathic Constipation (CIC) Drugs Market, By Geography, 2021
Figure 8 Market Geographical Opportunity Matrix - Global Global Chronic Idiopathic Constipation (CIC) Drugs Market, 2021
Figure 9 Market Positioning of Key Global Chronic Idiopathic Constipation (CIC) Drugs Market Players, 2021
Figure 10 Global Global Chronic Idiopathic Constipation (CIC) Drugs Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 11 Porters Five Force Model - Current, Midterm and Long Term Perspective
Figure 12 See Saw Analysis
Figure 13 PETEL Analysis
Figure 14 Key Buying Criteria: Current and Long-Term Perspective
Figure 15 Global Global Chronic Idiopathic Constipation (CIC) Drugs Market, Scenario Analysis, 2020 to 2030 (US$ Million)
Figure 16 Heptalysis Analysis: Global Global Chronic Idiopathic Constipation (CIC) Drugs Market
Figure 17 Five Whys Analysis
Figure 18 Global Global Chronic Idiopathic Constipation (CIC) Drugs Market, By Drug Type, 2021 Vs 2030, %
Figure 19 Global Global Chronic Idiopathic Constipation (CIC) Drugs Market, By Prescription Type, 2021 Vs 2030, %
Figure 20 U.S. Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 21 Canada Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 22 Rest of North America Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 23 UK Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 24 Germany Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 25 Spain Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 26 Italy Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 27 France Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 28 Rest of Europe Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 29 China Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 30 Japan Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 31 India Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 32 Australia Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 33 South Korea Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 34 Rest of Asia Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 35 Brazil Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 36 Mexico Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 37 Rest of Latin America Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 38 GCC Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 39 Africa Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030
Figure 40 Rest of Middle East and Africa Global Chronic Idiopathic Constipation (CIC) Drugs Market (US$ Million), 2020 - 2030List of Tables
Table 1 Global Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 2 Global Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 3 North America Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 4 North America Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 5 U.S. Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 6 U.S. Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 7 Canada Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 8 Canada Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 9 Rest of North America Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 10 Rest of North America Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 11 UK and European Union Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 12 UK and European Union Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 13 UK Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 14 UK Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 15 Germany Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 16 Germany Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 17 Spain Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 18 Spain Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 19 Italy Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 20 Italy Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 21 France Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 22 France Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 23 Rest of Europe Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 24 Rest of Europe Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 25 Asia Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 26 Asia Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 27 China Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 28 China Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 29 Japan Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 30 Japan Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 31 India Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 32 India Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 33 Australia Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 34 Australia Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 35 South Korea Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 36 South Korea Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 37 Latin America Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 38 Latin America Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 39 Brazil Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 40 Brazil Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 41 Mexico Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 42 Mexico Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 43 Rest of Latin America Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 44 Rest of Latin America Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 45 Middle East and Africa Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 46 Middle East and Africa Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 47 GCC Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 48 GCC Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 49 Africa Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 50 Africa Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 51 Rest of Middle East and Africa Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 52 Rest of Middle East and Africa Global Chronic Idiopathic Constipation (CIC) Drugs Market By Prescription Type, 2020-2030, USD (Million)
Companies Mentioned
- Actavis
- Chugai Pharmaceutical
- Ferring International Center S.A.
- Synergy Pharmaceuticals
- Pfizer
- GlaxoSmithKline
- Roche Holding AG
- Sanofi
- Bayer AG
- Salix Pharmaceuticals Ltd
- Sucampo Pharmaceuticals Inc
- Ironwood Pharmaceuticals inc
- Progenics pharmaceuticals inc
